Author: Timothy Donahue

  • Maryland Indoor Vaping Ban Goes Into Effect

    Maryland Indoor Vaping Ban Goes Into Effect

    Credit: Glynnis Jones

    A new amendment to Maryland’s Clean Indoor Air Act takes effect today, officially banning vaping in nearly all indoor public spaces and workplaces.

    First passed in 2007, the Clean Indoor Air Act originally prohibited smoking in public indoor spaces to “preserve and improve the health, comfort, and environment of the people of Maryland by limiting exposure to environmental smoke.”

    Beginning July 1st, 2024, that law now includes vaping after an amendment was passed in Maryland during the 2024 legislative session, according to WBOC.

    According to Maryland’s Department of Health, smoking and vaping of tobacco, cannabis, or hemp-derived products is banned in indoor areas open to the public, specifically public meeting places, public vehicles and indoor places of employment.

  • SCOTUS to Hear Vaping PMTA Suit FDA v. Triton

    SCOTUS to Hear Vaping PMTA Suit FDA v. Triton

    supreme court of USThe U.S. Supreme Court agreed on Tuesday to hear the U.S. Food and Drug Administration’s defense of the agency’s rejection of two companies’ premarket tobacco product applications (PMTAs) to sell flavored vape products that it has determined pose health risks for young consumers.

    The justices took up the FDA’s appeal filed after a lower court ruled that the agency had failed to follow proper legal procedures under federal law when it denied the applications to bring their nicotine-containing products to market.

    The Supreme Court is due to hear the case in its next term, which begins in October, according to Reuters.

    Two e-cigarette liquid makers, Triton Distribution and Vapetasia LLC, filed FDA applications in 2020 for products with flavors such as sour grape, pink lemonade, and crème brulee and names such as “Jimmy The Juice Man Strawberry Astronaut” and “Suicide Bunny Bunny Season.”

    An FDA rule that took effect in 2016 deemed e-cigarettes to be tobacco products, like traditional cigarettes, subject to agency review under a 2009 federal law called the Tobacco Control Act. The rule said manufacturers of the products would need to apply for approval to continue selling them.

    The FDA rejected the applications by the two companies, along with more than one million other products, according to court records. The FDA has approved only 27 e-cigarette products, all tobacco or menthol flavored.

    Triton and Vapetasia in 2021 asked the New Orleans-based 5th U.S. Circuit Court of Appeals to review the FDA’s denial of their applications.

    In January, the full slate of 5th Circuit judges ruled 10-6 that the FDA had been arbitrary and capricious, in violation of a federal law called the Administrative Procedure Act, by denying the applications without considering plans by the companies to prevent underage access and use.

  • Australia’s Vape Sales Restrictions Begin Today

    Australia’s Vape Sales Restrictions Begin Today

    Credit: Alexander

    Australia became the first country to restrict the sale of vapes to pharmacies when its new laws surrounding vaping products came into effect on Monday, stipulating sentences of up to seven years in prison and million-dollar fines.

    The law forces nicotine consumers who want a therapeutic vape to help quit smoking combustible cigarettes to consult their general practitioner and obtain a prescription to buy a therapeutic device from pharmacies.

    These products, whose access will be tightly controlled, will have plain packaging, and the flavors will be limited to tobacco, menthol and mint, according to media reports.

    “Australia has led the world in pushing back on Big Tobacco and fighting for the health of our citizens and we’re proud to continue that effort,” Australian Home Affairs Minister Claire O’Neil said in a statement released on Monday.

    Consumers over 18 years of age will be allowed to buy vapes with a maximum nicotine concentration of 20 mg/ml without a prescription until Oct. 1.

    Under the new reforms, businesses or individuals selling vapes will face a maximum sentence of seven years in prison and a fine of up to AU$2.2 million ($1.47 million), while companies that produce them would be subject to a maximum fine of around AU$22 million.

    The measures are part of amendments to the Therapeutic and Other Products (Vaping Reforms) Legislation 2024, which prohibits importing, manufacturing, distributing, and commercial possessing these devices, except with a license and special permit.

    The Australian government appointed Erin Dale as Commissioner for Tobacco and Illicit Electronic Cigarettes. Dale will assume the position on an interim basis on Monday until a formal appointment is made to intensify the fight against the expected rise in nicotine products on the black market.

    “Illegal tobacco is no different to any other illegal product – if you attempt to bring it into our country, you will be met by the full force of our border protection agencies,” O’Neil said.

    Several major pharmacy chains in Australia have stated that they will not stock vapes once their sale is prohibited outside of pharmacies and a prescription requirement for adults is lifted.

  • Reynolds Launches Disposable Non-Nicotine Vape

    Reynolds Launches Disposable Non-Nicotine Vape

    Credit: Casimiro

    R.J. Reynolds Vapor Company (RJRVC), an operating company of Reynolds American Inc. (Reynolds American), the BAT Group’s U.S. subsidiary, announced today that it is expanding its innovative vapor portfolio with SENSA, a zero-nicotine vapor product.

    As the market leader in vapor with its Vuse products, RJRVC is joining the growing marketplace for zero-nicotine vapor products and aims to establish the highest standards in the industry, according ot an emailed press release.

    SENSA products include a locking feature to prevent unintended usage, and adult consumers of the device will have access to Call2Recycle’s battery recycling program, which will facilitate the responsible disposal of SENSA batteries.

    “Adult tobacco and vapor consumers across the retail marketplace are looking for more options,” said Valerie Mras, senior vice president for RJRVC. “Adding a zero nicotine product to our growing vapor portfolio is driven by deep adult vapor consumer insights and enables us to responsibly compete within a category that is already well established in many countries.”

    The SENSA portfolio of flavors is intended for adult tobacco and vapor consumers and does not include flavors intended to appeal to those underage. The product will be responsibly marketed to adult tobacco and vapor consumers, consistent with the Reynolds American organization’s marketing practices for tobacco and nicotine products, according to the release.

    SENSA is intended to be sold only to adult tobacco and vapor consumers 21 and older; marketing touchpoints will be adult-oriented, and all web properties will be age-gated.

  • U.S. Supreme Court Overturns Chevron Deference

    U.S. Supreme Court Overturns Chevron Deference

    Credit: Sean Pavone Photo

    On Friday, June 28, the Supreme Court of the United States ruled 6-3 in favor of overturning the “Chevron deference,” a backbone principle for how the federal government keeps corporations in check. Chevron is the practice by which federal courts defer to federal agencies when sorting out ambiguities in a law. Justices Breyer, Kagan, and Sotomayor dissented.

    The ruling could impact the U.S. Food and Drug Administration and its process for authorizing vaping products through the premarket tobacco product authorization process. In practice, Chevron deference often gives agencies broad leeway to reach beyond the limits of a statute’s plain language, often bypassing the rulemaking process otherwise required under the Administrative Procedure Act and making it more difficult to challenge an agency action in court.

    Chris Howard, executive vice president, External Affairs & New Product Compliance for Swisher, said that for decades federal agencies have had too much power.

    “That ended today with the Supreme Court’s decision overturning the long-standing Chevron Doctrine. The decision marks a significant shift in the judicial landscape, correcting the balance of power between federal agencies and the judiciary,” said Howard. “It fundamentally alters how courts rule on agency statutory interpretation. As the majority states, courts will no longer be restrained by the need to provide deference.

    “Instead, ‘Courts must exercise their inde­pendent judgment in deciding whether an agency has acted within its statutory authority, as the APA requires.’ This transformation will likely lead to significantly less regulatory flexibility and increased judicial scrutiny. The implications of this decision will resonate across industries, including the tobacco industry, influencing regulatory practices and shaping the future of administrative law. Regulatory overreach will become the exception as opposed to the norm and enable courts to fulfill their duty to interpret the law.”

    In the years since electronic nicotine delivery systems (ENDS) became subject to FDA regulation, the vast majority of courts reviewing ENDS industry challenges to premarket application denials, as well as FDA rulemakings and guidance documents, have rubber-stamped the agency’s interpretation of the Family Smoking Prevention and Tobacco Control Act (TCA) and the “appropriate for the protection of the public health” standard.

    Critics contend that the Chevron deference has enabled the FDA to impermissibly interpret the TCA to implement a de facto ban on all nontobacco-flavored ENDS products without any requisite notice and comment rulemaking or congressional amendments to the TCA.

    “For far too long, unelected bureaucrats at the FDA have been making up the law to suit their own ulterior agenda and Today, the Supreme Court has thankfully put a stop to it once and for all,” said Allison Boughner, vice president of the American Vapor Manufacturers Association. “No longer will it be good enough for prohibitionists in Congress to write vague, Crayola language and then connive behind closed doors with FDA to impose arbitrary policies on the American public that could never withstand the light of day.”

    It has been nearly 40 years since the Supreme Court indicated in Chevron v. Natural Resources Defense Council that courts should defer to an agency’s reasonable interpretation of an ambiguous statute.

    The court’s ruling could have ripple effects across the federal government, where agencies frequently use highly trained experts to interpret and implement federal laws, according to SCOTUSblog. Although the doctrine was relatively noncontroversial when it was first introduced in 1984, in recent years conservatives – including some members of the Supreme Court – have called for it to be overturned.

    The plea to overturn the Chevron doctrine came to the court in two cases challenging a rule, issued by the National Marine Fisheries Service, that requires the herring industry to bear the costs of observers on fishing boats. Applying Chevron, both the U.S. Court of Appeals for the District of Columbia Circuit and the U.S. Court of Appeals for the 1st Circuit upheld the rule, finding it to be a reasonable interpretation of federal law.

    The fishing companies came to the Supreme Court, asking the justices to weigh in on the rule itself but also to overrule Chevron. Roman Martinez, representing one group of fishing vessels, told the justices that the Chevron doctrine undermines the duty of courts to say what the law is and violates the federal law governing administrative agencies, which similarly requires courts to undertake a fresh review of legal questions.

    Under the Chevron doctrine, he observed, even if all nine Supreme Court justices agree that the fishing vessels’ interpretation of federal fishing law is better than the NMFS’s interpretation, they would still be required to defer to the agency’s interpretation as long as it was reasonable. Such a result, Martinez concluded, is “not consistent with the rule of law.”

  • Australia: Major Pharmacies Against Vape Sales

    Australia: Major Pharmacies Against Vape Sales

    Credit: Jackie Davies

    Several major pharmacy chains in Australia have stated that they will not stock vapes once their sale is prohibited outside of pharmacies, and a prescription requirement for adults is lifted.

    In communications with their stakeholders, TerryWhite Chemmart, Priceline Pharmacy, National Pharmacies in South Australia, and 777 Group in West Australia all voiced strong disagreement with new laws allowing the sale of vapes without prescriptions.

    In a statement, The Pharmacy Guild of Australia said Blooms and thousands of independent pharmacies had also opposed the government’s deal with the Greens to open access for adults from October.

    Chemist Warehouse has told the ABC it is still looking at the implications of the decision and seeking more information on how it will work.

    While those pharmacies have indicated they will not be moving to stock vapes, franchisors under the brands are technically able to make an independent decision to do so.

    Many pharmacies under those brands already supply vapes nationwide or are licensed to do so. The key dispute raised by them is the “down scheduling” of vapes from October from requiring scripts to being available behind the counter for adults once they have had a conversation with their pharmacist.

    Health Minister Mark Butler said pharmacies would not be forced to stock vapes earlier this week, and the government did not expect that all pharmacies would.

  • Reynolds Files PMTA for Age-Gated Vuse Pro System

    Reynolds Files PMTA for Age-Gated Vuse Pro System

    R.J. Reynolds Vapor Co. has filed the final pre-market tobacco product application submissions with the U.S. Food and Drug Administration for its Vuse Pro age-gated device. The electronic nicotine delivery system device platform connects to a mobile application that verifies the consumer’s age through a third-party provider.

    Once verified, the device will unlock. It uses a unique design to only allow compatible Vuse Pro pods to be used. The technology and mobile application also enable features such as auto-lock and proximity lock to further secure device access.

    “Our PMTA submissions to the FDA underscore our commitment to both offering adult tobacco and vapor consumers choices as well as underage access prevention,” said Reynolds Executive Vice President of Scientific Research and Development Tim Nestor in a statement. “We don’t want our products in the hands of youth, period. The Vuse Pro ENDS platform provides a solution that limits access to adult consumers while also offering flavors that appeal to current adult smokers and a unique vapor experience.”

  • North Carolina Lawmakers Pass Vape Registry Bill

    North Carolina Lawmakers Pass Vape Registry Bill

    North Carolina Capitol Building in Raleigh (Credit: PaBrady 63)

    The North Carolina General Assembly has passed legislation to create a registry for vaping products, allowing for the sale of only a limited number of products.

    The Senate Judiciary Committee approved the proposal last week, and it advanced through its final committee stop Thursday, setting it up for a vote on the Senate floor. The proposal was added to HB 900, which deals with Wake County leadership academies.

    The new rules go into effect Dec. 1. Critics—including owners of vape stores and convenience stores that sell vaping products—say they could harm their bottom lines and potentially put them out of business.

    State lawmakers who support the bill cite health concerns and fears that vaping products are being marketed toward children using bright colors and sweet, candy-like flavors.

  • Altria Submits PMTA for ‘On! Plus’ Pouches

    Altria Submits PMTA for ‘On! Plus’ Pouches

    Image: maurice norbert

    Altria Group has submitted premarket tobacco product applications (PMTAs) to the U.S. Food and Drug Administration for its “On! Plus” oral nicotine pouch products. The PMTAs were submitted by Altria’s wholly owned subsidiary Helix Innovations.

    On! Plus is a spit-free, oral tobacco-derived nicotine (TDN) pouch product made from a proprietary “soft-feel” material to provide a more comfortable product experience. The On! Plus pouch is designed for adults who dip and adult dual users (i.e., adults who smoke and dip).

    According to Altria, On! Plus pouches are seamless and larger than the leading U.S. TDN brands. Similar to the currently marketed On! products, On! Plus packaging features a compartment to responsibly dispose of used product. Helix submitted PMTAs for three distinct On! Plus varieties: tobacco, mint and wintergreen. Each variety comes in three different nicotine strength options.

    “Helix’s submission of the On! Plus applications underscores Altria’s commitment to addressing consumers’ evolving preferences through innovation in potentially reduced risk products. We firmly believe that On! Plus is a transformative product that will meaningfully contribute to Helix’s growth in the U.S. market, upon timely FDA authorization,” said Nick MacPhee, managing director and general manager of Helix in a statement.

    “We’ve long believed in the value of a robust marketplace of authorized smoke-free products for adult tobacco consumers. We believe that these PMTAs demonstrate that responsibly marketed On! Plus pouches can provide a compelling alternative in the marketplace,” said Paige Magness, senior vice president of regulatory affairs, Altria Client Services.

    Upon authorization, Altria expects the products to be distributed by Altria Group Distribution Co.

    Helix currently sells On! nicotine pouches in the U.S. In the first quarter of 2024, On! shipment volume grew 32 percent versus the prior year and the brand achieved a 7.1 percent retail share of the total U.S. oral tobacco category.

    Altria entered the U.S. oral nicotine products market in 2019 after signing a deal with Burger Söhne to acquire an 80 percent ownership stake in some companies that commercialized On! Products, according to The Wall Street Journal. In December 2020 and April 2021, Altria subsidiaries concluded transactions to buy the remaining 20 percent stake of the global on! business for about $250 million.

    Altria’s PMTA announcement comes after Philip Morris International’s Swedish Match North America unit suspended nationwide sales on its U.S. website as local officials in Washington, D.C., investigate whether the company is in compliance with the district’s ban on the sale of flavored products.

  • US Customs Seizes 53,700 Illegal Flavored Vape Pens

    US Customs Seizes 53,700 Illegal Flavored Vape Pens

    U.S. Customs and Border Protection (CBP) officers in Chicago recently seized 53,700 electronic nicotine delivery systems (ENDS) for violating the U.S. Food and Drug Administration’s Federal Food, Drug, and Cosmetic Act (FD&C Act).

    The shipment, originating from China, was destined for a wholesaler in Mississippi, according to a CBP release.

    The vaping pens were inspected by CBP and the FDA, and it was determined that the shipment violated the FD&C Act as it consisted of adulterated consumer goods being imported by an unauthorized agent. On June 10, the FDA announced the establishment of a federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes.

    “Our officers are dedicated to identifying and intercepting these types of shipments that could potentially harm the health and wellbeing of people within our communities,” said LaFonda Sutton-Burke, Direction Field Operations, Chicago Field Officer. “Customs and Border Protection’s trade enforcement mission places a significant emphasis on intercepting illicit products that could harm American consumers, and we will continue to work with our consumer product safety partners to identify and seize unsafe and illicit goods.”

    The 179 boxes were mislabeled as electronic atomizers, a common practice used to smuggle unapproved goods into the U.S. CBP presumes the products were being sent to a wholesaler for wider distribution throughout the country. CBP continues to work diligently to stop non-legitimate products from entering the U.S. The ENDs had a combined Manufacturer’s Suggest Retail Price of over $1.08 million.